Fibrinaloid Microclot Complexes in Chronic Inflammatory Diseases such as Long COVID and M.E.

Long COVID, M.E. and other chronic inflammatory diseases continue to present significant challenges for both patients and clinicians. Could fibrinaloid microclots be one of the missing pieces of the puzzle?

In this upcoming AONM webinar, Professor Douglas Kell will explore the growing body of research surrounding fibrinaloid (amyloid fibrin) microclots and their potential role in impaired microcirculation, reduced oxygen delivery, and the persistent symptoms experienced in conditions such as Long COVID and M.E.

Drawing on decades of research and a programme of work that has helped shape our understanding of fibrinaloid microclots alongside Professor Resia Pretorius, Professor Kell will explain the biology behind these abnormal clots, why they may evade conventional testing, and what current evidence suggests about their role in chronic inflammatory disease.

The webinar will also discuss emerging approaches to supporting fibrinolysis, including the evidence surrounding enzymes and other candidate nutraceuticals, while emphasising the importance of working alongside healthcare professionals when considering any therapeutic interventions.

Whether you’re a healthcare practitioner, researcher, or someone with an interest in the latest developments in Long COVID and M.E. research, this webinar offers an evidence-informed overview of one of the most rapidly evolving areas of chronic disease research.